Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Tofacitinib taken by mouth helps treat hair loss in children.

Platelet-rich plasma (PRP) can significantly improve melasma, a skin pigmentation disorder, but may not add benefits when used with certain other treatments.

Haloperidol decanoate can cause alopecia areata.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

The ethosomal delivery system improves topical drug delivery and promotes hair growth.

5-aminosalicylic acid enemas may cause hair loss.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Isotretinoin may effectively treat hereditary hypotrichosis simplex, a rare hair loss condition.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

ICP5249 helps hair grow by activating a specific cell pathway.

Semaglutide does not significantly increase the risk of hair loss.

Triamcinolone acetonide mesotherapy may be effective for treating patchy hair loss in alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.